Asthma Management with Inhaled Corticosteroids

Clinical Reasoning for Treatment

The American Thoracic Society recommends that patients with asthma should receive inhaled corticosteroids even in the absence of wheeze and with good air entry, as asthma can present with minimal or no audible wheeze, and inhaled corticosteroids remain the first-line treatment for persistent asthma regardless of physical examination findings 1, 2
Cough variant asthma presents as chronic cough without wheeze or dyspnea, yet still requires inhaled corticosteroid therapy as first-line treatment, according to the American College of Chest Physicians 1, 2
The absence of wheeze on examination does not exclude significant airway inflammation or the need for anti-inflammatory therapy, as stated by the American Thoracic Society 1
Physical examination findings in asthma are often non-diagnostic, and normal lung sounds do not rule out underlying eosinophilic inflammation requiring corticosteroid treatment, as noted by the American College of Chest Physicians 1

For adult and adolescent patients with chronic cough due to asthma as a unique symptom, inhaled corticosteroids should be considered as first-line treatment (Grade 1B), according to the American College of Chest Physicians 1, 2
Low-dose inhaled corticosteroids are the most effective single long-term controller medication for persistent asthma, as recommended by the American Academy of Family Physicians 4
Inhaled corticosteroids improve symptom scores, lower exacerbation rates, reduce symptom frequency, and decrease the need for rescue medications compared to other single long-term control medications, as stated by the American Academy of Family Physicians 4

Start with low-dose inhaled corticosteroids (fluticasone 100-250 mcg/day or equivalent) administered twice daily, as recommended by the American College of Chest Physicians 3
Use a spacer device to enhance lung deposition and reduce local side effects, and have the patient rinse their mouth after each use, as advised by the American Academy of Family Physicians 5

If response is incomplete after 4-6 weeks, step up the inhaled corticosteroid dose and consider adding a leukotriene inhibitor after reconsidering alternative causes of cough, as recommended by the American College of Chest Physicians 1, 2
For patients ≥12 years with inadequate control on low-dose inhaled corticosteroids, adding a long-acting beta-agonist (LABA) is the preferred adjunctive therapy rather than simply increasing the corticosteroid dose, as stated by the American Academy of Family Physicians 4, 3

The presence of concurrent bronchitic symptoms does not negate the need for inhaled corticosteroid therapy in patients with established asthma, as noted by the American College of Chest Physicians 1, 2

Non-invasive measurement of airway inflammation has clinical utility, and the presence of eosinophilic airway inflammation is likely to be associated with a more favorable response to corticosteroids (Grade 2B), as stated by the American Thoracic Society 1, 2

Do not withhold inhaled corticosteroids based solely on the absence of wheeze on physical examination, as asthma can present without audible wheeze, particularly in cough variant asthma, as advised by the American College of Chest Physicians 1, 2
Do not use short-acting beta-agonists alone as long-term management, as using rescue inhalers more than 2 days per week for symptom relief indicates inadequate control and the need to initiate or intensify anti-inflammatory therapy, as noted by the American Academy of Family Physicians 4, 3
Never use long-acting beta-agonists as monotherapy without inhaled corticosteroids, as this increases the risk of asthma exacerbations, as warned by the American Academy of Family Physicians 4, 3

Reassess asthma control every 2-6 weeks initially after starting treatment, as recommended by the American College of Chest Physicians 3, 5
If no clear benefit is observed within 4-6 weeks, reconsider alternative diagnoses or step up therapy, as advised by the American College of Chest Physicians 1, 3